Intermittent EGFR-TKI therapy is associated with durable response in advanced EGFR-mutant NSCLC: a case report
Madam S, who diagnosed to have stage IV lung adenocarcinoma with exon 21 L858R point mutation (T3N2M1a) was admitted for massive pericardial effusion in April 2016. She was ECOG 4 on admission. Her ECOG improved to 1 after pericardial tapping and initiation of free sample erlotinib 100 mg daily. Rep...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English English |
Published: |
Faculty of Medicine and Health Sciences, University Putra Malaysia
2023
|
Subjects: | |
Online Access: | http://irep.iium.edu.my/108703/7/108703_Intermittent%20EGFR-TKI%20therapy%20is%20associated%20with%20durable%20response.pdf http://irep.iium.edu.my/108703/8/108703_Intermittent%20EGFR-TKI%20therapy%20is%20associated%20with%20durable%20response_Scopus.pdf http://irep.iium.edu.my/108703/ https://medic.upm.edu.my/jurnal_kami/volume_19_2023/mjmhs_vol19_no_2_march_2023-72022 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
http://irep.iium.edu.my/108703/7/108703_Intermittent%20EGFR-TKI%20therapy%20is%20associated%20with%20durable%20response.pdfhttp://irep.iium.edu.my/108703/8/108703_Intermittent%20EGFR-TKI%20therapy%20is%20associated%20with%20durable%20response_Scopus.pdf
http://irep.iium.edu.my/108703/
https://medic.upm.edu.my/jurnal_kami/volume_19_2023/mjmhs_vol19_no_2_march_2023-72022